Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Expected to Announce Earnings of $0.17 Per Share

Wall Street analysts expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to post earnings of $0.17 per share for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Allscripts Healthcare Solutions’ earnings. The highest EPS estimate is $0.25 and the lowest is $0.13. Allscripts Healthcare Solutions posted earnings per share of $0.18 during the same quarter last year, which would indicate a negative year over year growth rate of 5.6%. The business is expected to issue its next quarterly earnings results on Thursday, July 29th.

On average, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.73 per share for the current financial year, with EPS estimates ranging from $0.58 to $0.98. For the next fiscal year, analysts expect that the business will post earnings of $0.79 per share, with EPS estimates ranging from $0.61 to $0.97. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Wednesday, April 28th. The software maker reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Allscripts Healthcare Solutions had a net margin of 46.70% and a return on equity of 7.17%. The business had revenue of $368.40 million for the quarter, compared to analyst estimates of $368.42 million. During the same period last year, the business posted $0.09 earnings per share.

MDRX has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Allscripts Healthcare Solutions from $15.00 to $17.00 and gave the stock a “hold” rating in a report on Thursday, May 20th. Piper Sandler lowered their price target on shares of Allscripts Healthcare Solutions from $17.00 to $15.00 and set a “neutral” rating on the stock in a research note on Friday, February 26th. Canaccord Genuity lifted their price target on shares of Allscripts Healthcare Solutions from $17.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, April 30th. Argus reiterated a “hold” rating on shares of Allscripts Healthcare Solutions in a research note on Monday, March 8th. Finally, SVB Leerink lifted their price target on shares of Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company a “market perform” rating in a research note on Wednesday, May 26th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $13.17.

Shares of NASDAQ:MDRX traded up $0.03 during midday trading on Friday, reaching $18.08. 26,950 shares of the company were exchanged, compared to its average volume of 1,822,746. Allscripts Healthcare Solutions has a fifty-two week low of $5.77 and a fifty-two week high of $18.20. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.29 and a current ratio of 1.29. The stock’s fifty day moving average price is $16.48. The firm has a market cap of $2.55 billion, a price-to-earnings ratio of 3.74, a PEG ratio of 3.97 and a beta of 1.08.

Allscripts Healthcare Solutions declared that its Board of Directors has approved a share repurchase plan on Wednesday, May 26th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the software maker to buy up to 14% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

In related news, CEO Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Monday, March 15th. The shares were sold at an average price of $15.72, for a total transaction of $943,200.00. Also, Director Michael Klayko sold 28,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Tuesday, June 8th. The stock was sold at an average price of $18.03, for a total transaction of $504,840.00. Following the sale, the director now directly owns 38,581 shares of the company’s stock, valued at approximately $695,615.43. The disclosure for this sale can be found here. In the last three months, insiders sold 201,000 shares of company stock valued at $3,482,040. Insiders own 1.91% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Eaton Vance Management bought a new stake in shares of Allscripts Healthcare Solutions during the 1st quarter worth about $30,000. Point72 Hong Kong Ltd boosted its holdings in Allscripts Healthcare Solutions by 152.9% in the 1st quarter. Point72 Hong Kong Ltd now owns 2,119 shares of the software maker’s stock valued at $32,000 after purchasing an additional 1,281 shares during the period. Vantage Consulting Group Inc bought a new stake in Allscripts Healthcare Solutions in the 4th quarter valued at about $44,000. Veriti Management LLC bought a new stake in Allscripts Healthcare Solutions in the 4th quarter valued at about $89,000. Finally, Eqis Capital Management Inc. bought a new stake in Allscripts Healthcare Solutions in the 4th quarter valued at about $158,000.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More: Total Return

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.